Co-Authors
This is a "connection" page, showing publications co-authored by Faryal Khamis and Nenad Pandak.
Connection Strength
1.308
-
Prevalence and predictors of in-hospital mortality of patients hospitalized with COVID-19 infection. J Infect Public Health. 2021 Jun; 14(6):759-765.
Score: 0.235
-
The Role of Convalescent Plasma and Tocilizumab in the Management of COVID-19 Infection: A Cohort of 110 Patients from a Tertiary Care Hospital in Oman. J Epidemiol Glob Health. 2021 06; 11(2):216-223.
Score: 0.231
-
Randomized controlled open label trial on the use of favipiravir combined with inhaled interferon beta-1b in hospitalized patients with moderate to severe COVID-19 pneumonia. Int J Infect Dis. 2021 Jan; 102:538-543.
Score: 0.228
-
Therapeutic plasma exchange in adults with severe COVID-19 infection. Int J Infect Dis. 2020 Oct; 99:214-218.
Score: 0.222
-
Clinical characteristics and outcomes of the first 63 adult patients hospitalized with COVID-19: An experience from Oman. J Infect Public Health. 2020 Jul; 13(7):906-913.
Score: 0.222
-
Immunological predictors of disease severity in patients with COVID-19. Int J Infect Dis. 2021 Sep; 110:83-92.
Score: 0.060
-
Corrigendum to "A fatal case of COVID-19 due to metabolic acidosis following dysregulate inflammatory response (cytokine storm)" [ID Cases 21 (2020) e00829]. IDCases. 2020 Jun 11; e00865.
Score: 0.055
-
A fatal case of COVID-19 due to metabolic acidosis following dysregulate inflammatory response (cytokine storm). IDCases. 2020; 21:e00829.
Score: 0.055